South Korea

Fourteen countries and European Commission express concern about WHO Covid-19 origin report

Submitted by mike kraft on Tue, 2021-03-30 19:44

U.S., 13 countries concerned WHO COVID-19 origin study was delayed, lacked access -statement The United States and 13 other countries expressed concerns on Tuesday that the World Health Organization (WHO) report on the origins of the novel coronavirus that causes COVID-19 was delayed and lacked access to complete data, according to a joint statement. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Fourteen countries and European Commission express concern about WHO Covid-19 origin report
Log in or register to post comments

OVERVIEW: COVID-19 International briefs

Submitted by mike kraft on Fri, 2021-03-19 10:59

Factbox: Latest on the worldwide spread of the coronavirus Britain said on Thursday that there were lumps and bumps in the global vaccine supply chain that were causing slower than expected deliveries and scolded the European Union for threatening to slap a ban on vaccine exports. Reuters Staff U.S.

(Reuters) - Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said its benefits outweighed any risks. Reports of rare instances of blood clotting had temporarily halted inoculations.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about OVERVIEW: COVID-19 International briefs
Log in or register to post comments

Overview: International and U.S roundups--AP and Reuters

Submitted by mike kraft on Fri, 2021-03-12 11:46

The Latest: Japan to tighten border control against variants TOKYO — Transportation minister Kazuyoshi Akaba says Japan will tighten border controls and limit the number of entrants to up to 2,000 per day to guard against the more contagious variants of the... AP NEWS

TOKYO — Transportation minister Kazuyoshi Akaba says Japan will tighten border controls and limit the number of entrants to up to 2,000 per day to guard against the more contagious variants of the coronavirus.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Overview: International and U.S roundups--AP and Reuters
Log in or register to post comments

Novavax vaccine showing high effectiveness against original coronavirus and British variant

Submitted by mike kraft on Thu, 2021-03-11 19:22

Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial Novavax Inc's COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval. Dania Nadeem, Carl O’Donnell U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Novavax vaccine showing high effectiveness against original coronavirus and British variant
Log in or register to post comments

Asia Developments, South Korea first shots, China approves 2 more vaccines

Submitted by mike kraft on Fri, 2021-02-26 10:25

Asia Today: 1st vaccines reach arms in S. Korea, Hong Kong South Korea administered its first available shots of coronavirus vaccines to people at long-term care facilities Friday, launching a mass immunization campaign that health authorities hope will... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Asia Developments, South Korea first shots, China approves 2 more vaccines
1 comment
Log in or register to post comments

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use

Submitted by mike kraft on Tue, 2021-02-16 22:47

WHO lists two additional COVID-19 vaccines for emergency use and COVAX roll-out Today WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX.

WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be rolled out globally through COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use
Log in or register to post comments

Overview: COVID-19 International brief developments

Submitted by mike kraft on Tue, 2021-02-09 11:39

Factbox: Latest on the worldwide spread of the coronavirus The head of the World Health Organization-led team in Wuhan that is investigating the origins of COVID-19 said that cold chain transmission of the virus was a possibility and warranted further investigation. Reuters Staff U.S.

* Germany is planning to spend nearly 9 billion euros this year to buy up to 635.1 million COVID-19 vaccines as part of the European Union’s procurement scheme and national deals.

Country / Region Tags:

General Topic Tags: